ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TECX vs CCCC // EV/EBITDA & P/E VALUATION

Tectonic Therapeutic Inc. (NASDAQ) VS. C4 Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: TECX 1 — CCCC 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TECX VS. CCCC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TECX CCCC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -15.04% -24.46% +9.42 TECX /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 1.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 CCCC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.8 57.0 -26.28 CCCC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $400.8M $406.0M -$5.2M CCCC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TECX REV CCCC REV TECX GROSS % CCCC GROSS % TECX FCF CCCC FCF
FY 2025 $0 $35.9M — — -$60.3M -$99.3M
FY 2024 $0 $35.6M — — -$59.2M -$65.3M
FY 2023 $0 $20.8M — — -$40.7M -$106.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TECX // BETA —
CCCC // BETA —